Entasis Therapeutics Holdings Inc (NASDAQ:ETTX)

North American company
add to virtual portfolio
This share can be held in
Trading AccountISAJISASIPP

Share Price Chart

- Chart currently unavailable -

Market Info - ETTX

  • Market Open Price0.00
  • Previous Close0.00
  • Volume-
  • 52w Low/High-
  • Last Trade Price0.00
  • Bid/Ask Price0.00

Company Info - ETTX

  • Market Cap$93.660m
  • IndustryHealthcare
  • SectorBiotechnology
  • Currency
  • ISINUS2936141033

Company Profile

Entasis Therapeutics Holdings Inc is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria. Its products candidate includes Zoliflodacin, ETX0282CPDP, and NBP program.

Latest ETTX news

Currently there for this company. Visit our news hub for other news .